Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Akash Kulgod pointed out that analytical chemistry standards like GCMS detect volatile compounds at parts per million, whereas canine olfactory bulbs detect parts per trillion. This sensitivity difference allows dogs to spot stage 1 and 2 cancers easily while ignoring external confounds like recent smoking or specific diets.

Related Insights

True early cancer detection involves finding microscopic tumor DNA in blood samples. This can identify cancer years before it's visible on an MRI, creating an opportunity for a patient's own immune system to potentially eliminate it before it ever becomes a clinical disease.

Akash Kulgod shared how Dognosis partnered with Singapore security forces to deploy canine wearables after explosions. Rather than relying on a handler visually reading a dog, the harness pairs GPS tracking with real-time EEG readouts to automatically project chemical residue heatmaps across a full 3D spatial model.

Akash Kulgod noted that because baseline cancer prevalence in healthy populations is under 1%, even tests with 90% or 99% accuracy create massive false positives. Dognosis solves this statistical trap by using breath as an initial sensitive triage, followed by imaging to confirm true structural abnormalities.

The study found that dogs could detect a wide range of cancers (head and neck, breast, lung, GI) with consistently high sensitivity. This accuracy held even for Stage 1 cancers, suggesting the presence of a universal volatile organic compound signature in breath that is detectable regardless of tumor type or stage.

Akash Kulgod explained that training dogs to give binary physical alerts like sitting or pawing takes 12 months and loses nuanced data. Replacing physical actions with brain-computer interfaces cut training down to eight weeks. Sensors capture brainwaves and heart rates to measure confidence, focus, and ambiguity directly.

Akash Kulgod noted that artificial intelligence models can process visual and auditory data but cannot smell because no internet of smells exists. Dognosis plans to record dog neural representations of odors to build a perceptual smell dataset, creating reinforcement learning from canine feedback to finally teach AI olfaction.

Digitizing smell has been impossible until now because the human nose has over 300 sensory "channels," compared to just three for color (RGB). This complexity required mature AI to create the high-dimensional "map" needed to interpret and organize scent data, a task too complex for previous technologies.

The efficacy of cancer-detecting dogs lies not in identifying a single biomarker but in recognizing a complex, irregular pattern among thousands of emitted chemicals. This suggests that creating an artificial 'nose' for diagnostics requires modeling complex systems, not just searching for a specific molecule, a task well-suited for AI.

High-sensitivity molecular assays frequently identify cancer signatures in patients whose visual endoscopic examinations appear negative. Clinical evaluation revealed that one-third of these seeming diagnostic discordances were true early-stage cancers caught before becoming visually detectable.

Akash Kulgod observed that dogs naturally experience off-days roughly 10% of the time, degrading test consistency. Dognosis addresses this by having five dogs sniff each sample while AI models track neurological stress and engagement. The system dynamically downweights scores from unfocused dogs to produce a reliable consensus.